Tuesday, February 24, 2015.
In a new PLOS blog publication (link) Peter Hotez and Jennifer Herricks write about diseases that cause the most child (>5 years) deaths. Nutritional deficiencies still kill more than 200,000 young children annually, many of them from protein-energy malnutrition, but there are other causes including severe anemia that results from hookworm infection, together with other parasitic diseases. Our Sabin Vaccine Institute and Texas Children’s Hospital Center for Vaccine Development is developing a new human hookworm vaccine in collaboration with a HOOKVAC consortium based in Europe and supported by the European Union and Dutch Government, which if successful could reduce the number of deaths from malnutrition. Continue reading
Thursday, February 19, 2015
The Health Affairs posted a blog written by Peter Hotez and Remko van Leeuwen that describes the role of HOOKVAC in vaccinating against Iron-Deficiency Anemia (IDA). As they explain: “While several factors contribute to IDA, including dietary deficiencies and iron losses through menstruation and pregnancy, human hookworm infection has been identified as one of the leading causes in impoverished countries, especially in sub-Saharan Africa, Southeast Asia, and Oceania. Hookworms are parasitic worms that attach to the inside of the intestines of children and women. Hookworms are long-lived parasites, extracting blood every day to produce sufficient blood loss that results in IDA”. Read the complete blog here: http://healthaffairs.org/blog/2015/02/19/vaccinating-against-iron-deficiency-anemia-a-new-technology-for-maternal-and-child-health/
Thursday, December 4, 2014
The Delegation of European Union to India and EuropeAid have awarded partners in the HOOKVAC consortium a grant to develop a EU-India research and innovation partnership. The following objectives are part of the grant:
- To establish an EU-India academic, cluster partnership to facilitate a long-term manufacturing partnership for the human hookworm vaccine and other NTD vaccines.
- To transfer technology from European manufacturers to Indian manufacturers for NTD vaccines
- To improve manufacturing methods to create efficiency and economy of scale
- To establish a creative environment environment for joined development of new innovative and low cost vaccines for NTDs and other poverty related diseases.
- To set-up individual mobility schemes for researchers and innovators from the HOOKVAC consortium (EU/US/ based institutes) working in research and innovation to move from the Europe cluster to India. The individual mobility schemes will be an integral component of the cluster-to-cluster partnerships.
- To support and encourage visibility, mutual understanding and awareness for low-cost vaccine development for neglected tropical diseases via meetings and workshops.